FDA Import Refusal AEK-8401476-8/51/1 — Novartis Pharmaceuticals Corporation

Novartis Pharmaceuticals Corporation — FEI 2210396

The FDA refused shipment AEK-8401476-8/51/1 from Novartis Pharmaceuticals Corporation (United States) on May 28, 2025. The refused product falls under Drugs and Biologics — AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.